fbpx Skip to main content

Member's Profile

Mirati Therapeutics

Location
3545 Cray Court
San Diego,   California
92121-3070
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2014
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Mirati Therapeutics
Biotech Company
Mirati Therapeutics Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, MRTX1719, an investigational
Related News
No related news posted by this Member